These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1268 related items for PubMed ID: 26991109

  • 1. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK, Yun S, Koh J, Kwak Y, Seo AN, Park KU, Kim DW, Kang SB, Kim WH, Lee HS.
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [Abstract] [Full Text] [Related]

  • 2. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.
    BMC Cancer; 2008 Sep 09; 8():255. PubMed ID: 18782444
    [Abstract] [Full Text] [Related]

  • 3. Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.
    Wojas-Krawczyk K, Kalinka-Warzocha E, Reszka K, Nicoś M, Szumiło J, Mańdziuk S, Szczepaniak K, Kupnicka D, Lewandowski R, Milanowski J, Krawczyk P.
    Adv Clin Exp Med; 2019 Jan 09; 28(1):67-73. PubMed ID: 30085422
    [Abstract] [Full Text] [Related]

  • 4. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
    Palomba G, Doneddu V, Cossu A, Paliogiannis P, Manca A, Casula M, Colombino M, Lanzillo A, Defraia E, Pazzola A, Sanna G, Putzu C, Ortu S, Scartozzi M, Ionta MT, Baldino G, Sarobba G, Capelli F, Sedda T, Virdis L, Barca M, Gramignano G, Budroni M, Tanda F, Palmieri G.
    J Transl Med; 2016 Oct 13; 14(1):292. PubMed ID: 27737711
    [Abstract] [Full Text] [Related]

  • 5. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Løes IM, Immervoll H, Sorbye H, Angelsen JH, Horn A, Knappskog S, Lønning PE.
    Int J Cancer; 2016 Aug 01; 139(3):647-56. PubMed ID: 26991344
    [Abstract] [Full Text] [Related]

  • 6. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].
    Ling Y, Ying JM, Qiu T, Shan L, Guo L, Lü N.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 01; 41(9):590-4. PubMed ID: 23157825
    [Abstract] [Full Text] [Related]

  • 7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B, Kempa M, Novy M, Oberkanins C, Xu L, Li G, Loland C, Poetsch M.
    Int J Clin Exp Pathol; 2014 Sep 01; 7(9):5927-39. PubMed ID: 25337237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.
    Shen Y, Wang J, Han X, Yang H, Wang S, Lin D, Shi Y.
    PLoS One; 2013 Sep 01; 8(12):e81628. PubMed ID: 24339949
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF, Sadowska J, Huse JT, Borsu L, Yaeger R, Shia J, Vakiani E, Ladanyi M, Arcila ME.
    Mol Cancer Res; 2015 Jun 01; 13(6):1003-8. PubMed ID: 25714871
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.
    Won DD, Lee JI, Lee IK, Oh ST, Jung ES, Lee SH.
    BMC Cancer; 2017 Jun 05; 17(1):403. PubMed ID: 28583095
    [Abstract] [Full Text] [Related]

  • 15. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K, Yamamoto G, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.
    Oncol Rep; 2017 Feb 05; 37(2):785-792. PubMed ID: 28000889
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
    Nazemalhosseini-Mojarad E, Kishani Farahani R, Mehrizi M, Baghaei K, Yaghoob Taleghani M, Golmohammadi M, Peyravian N, Ashtari S, Pourhoseingholi MA, Asadzadeh Aghdaei H, Zali MR.
    J Gastrointest Cancer; 2020 Mar 05; 51(1):53-62. PubMed ID: 30635874
    [Abstract] [Full Text] [Related]

  • 17. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ, Kim JW, Jung JP, Cho JW, Nam ES, Cho SJ, Kim JS, Park HR, Min SK, Seo J, Min KW, Kim DH, Jeon JY.
    Hum Pathol; 2016 Apr 05; 50():90-100. PubMed ID: 26997442
    [Abstract] [Full Text] [Related]

  • 18. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
    Guedes JG, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, Peixoto A, Fragoso M, Raimundo A, Ferreira P, Machado M, Sousa N, Lopes P, Araújo A, Macedo J, Alves F, Coutinho C, Henrique R, Santos LL, Teixeira MR.
    BMC Cancer; 2013 Apr 01; 13():169. PubMed ID: 23548132
    [Abstract] [Full Text] [Related]

  • 19. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.
    Chen J, Guo F, Shi X, Zhang L, Zhang A, Jin H, He Y.
    BMC Cancer; 2014 Nov 03; 14():802. PubMed ID: 25367198
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
    Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE.
    Clin Cancer Res; 2010 Feb 01; 16(3):790-9. PubMed ID: 20103678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.